Soleno Therapeutics (SLNO) Shares Outstanding (Diluted) (2014 - 2026)

Soleno Therapeutics (SLNO) Shares Outstanding (Diluted) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 52.24 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 256.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 680.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 66.36 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 Soleno Therapeutics 874.25 Mn 618.67 Mn 93.41 Mn 53.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 53.07 Mn
Dec 31, 2025 52.38 Mn
Sep 30, 2025 54.92 Mn
Jun 30, 2025 50.48 Mn
Mar 31, 2025 46.18 Mn
Dec 31, 2024 40.18 Mn
Sep 30, 2024 41.88 Mn
Jun 30, 2024 38.63 Mn
Mar 31, 2024 36.21 Mn
Dec 31, 2023 16.49 Mn
Sep 30, 2023 11.44 Mn
Jun 30, 2023 10.42 Mn
Mar 31, 2023 9.45 Mn
Dec 31, 2022 8.40 Mn
Sep 30, 2022 8.09 Mn
Jun 30, 2022 8.01 Mn
Mar 31, 2022 5.33 Mn
Dec 31, 2021 5.32 Mn
Sep 30, 2021 5.32 Mn
Jun 30, 2021 5.32 Mn